|
Type 2 diabetes
Citations 331-340 of 449 total displayed.
|
Past content
(since Jan 2001):
|
- Clinical Investigations and Reports
Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes
- Michaela Scheuermann-Freestone, Per L. Madsen, David Manners, Andrew M. Blamire, Robin E. Buckingham, Peter Styles, George K. Radda, Stefan Neubauer, and Kieran Clarke
Circulation 2003;107:3040-3046; published online before print as doi:10.1161/01.CIR.0000072789.89096.10
[Abstract]
[Full text]
- Articles
Increased Expression of Thrombospondin-1 in Vessel Wall of Diabetic Zucker Rat
- Olga I. Stenina, Irene Krukovets, Kai Wang, Zhongmin Zhou, Farhad Forudi, Marc S. Penn, Eric J. Topol, and Edward F. Plow
Circulation published June 16, 2003, doi:10.1161/01.CIR.0000074223.56882.97
[Abstract]
- Articles
Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes
- Michaela Scheuermann-Freestone, Per L. Madsen, David Manners, Andrew M. Blamire, Robin E. Buckingham, Peter Styles, George K. Radda, Stefan Neubauer, and Kieran Clarke
Circulation published June 16, 2003, doi:10.1161/01.CIR.0000072789.89096.10
[Abstract]
- Clinical Investigations and Reports
Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic Patients: A Novel Target of Thiazolidinediones
- Nerea Varo, David Vicent, Peter Libby, Rebecca Nuzzo, Alfonso L. Calle-Pascual, María Rosa Bernal, Arturo Fernández-Cruz, Aristidis Veves, Petr Jarolim, Jose Javier Varo, Allison Goldfine, Edward Horton, and Uwe Schönbeck
Circulation 2003;107:2664-2669; published online before print as doi:10.1161/01.CIR.0000074043.46437.44
[Abstract]
[Full text]
- Brief Rapid Communications
Inhibitory Activity of Clinical Thiazolidinedione Peroxisome Proliferator Activating Receptor- Ligands Toward Internal Mammary Artery, Radial Artery, and Saphenous Vein Smooth Muscle Cell Proliferation
- Stephanie T. de Dios, Dennis Bruemmer, Rodney J. Dilley, Melanie E. Ivey, Garry L.R. Jennings, Ronald E. Law, and Peter J. Little
Circulation 2003;107:2548-2550; published online before print as doi:10.1161/01.CIR.0000074040.31731.96
[Abstract]
[Full text]
- Editorials
Active Lifestyle and Diabetes
- Jonathan Myers, J. Edwin Atwood, and Victor Froelicher
Circulation 2003;107:2392-2394, doi:10.1161/01.CIR.0000067882.00596.FC
[Full text]
- Clinical Investigations and Reports
Physical Activity in Relation to Cardiovascular Disease and Total Mortality Among Men With Type 2 Diabetes
- Mihaela Tanasescu, Michael F. Leitzmann, Eric B. Rimm, and Frank B. Hu
Circulation 2003;107:2435-2439; published online before print as doi:10.1161/01.CIR.0000066906.11109.1F
[Abstract]
[Full text]
- Clinical Investigations and Reports
Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic Patients: A Novel Target of Thiazolidinediones
- Nerea Varo, David Vicent, Peter Libby, Rebecca Nuzzo, Alfonso L. Calle-Pascual, María Rosa Bernal, Arturo Fernández-Cruz, Aristidis Veves, Petr Jarolim, Jose Javier Varo, Allison Goldfine, Edward Horton, and Uwe Schönbeck
Circulation published May 12, 2003, doi:10.1161/01.CIR.0000074043.46437.44
[Abstract]
[Full text]
- Articles
Inhibitory Activity of Clinical Thiazolidinedione Peroxisome Proliferator Activating Receptor- Ligands Toward Internal Mammary Artery, Radial Artery, and Saphenous Vein Smooth Muscle Cell Proliferation
- Stephanie T. de Dios, Dennis Bruemmer, Rodney J. Dilley, Melanie E. Ivey, Garry L.R. Jennings, Ronald E. Law, and Peter J. Little
Circulation published May 12, 2003, doi:10.1161/01.CIR.0000074040.31731.96
[Abstract]
- Clinical Investigations and Reports
Prospective Investigation of Autonomic Nervous System Function and the Development of Type 2 Diabetes: The Atherosclerosis Risk In Communities Study, 1987–1998
- Mercedes R. Carnethon, Sherita H. Golden, Aaron R. Folsom, William Haskell, and Duanping Liao
Circulation 2003;107:2190-2195; published online before print as doi:10.1161/01.CIR.0000066324.74807.95
[Abstract]
[Full text]
|
|
